13 May 2025 Date | | - Cons. EPS | - EPS |
25 Feb 2025 Date | | - Cons. EPS | - EPS |
7 Nov 2024 Date | | - Cons. EPS | - EPS |
31 Oct 2024 Date | | - Cons. EPS | - EPS |
2 Oct 2024 Date | | - Cons. EPS | - EPS |
13 May 2025 Date | | - Cons. EPS | - EPS |
25 Feb 2025 Date | | - Cons. EPS | - EPS |
7 Nov 2024 Date | | - Cons. EPS | - EPS |
31 Oct 2024 Date | | - Cons. EPS | - EPS |
2 Oct 2024 Date | | - Cons. EPS | - EPS |
Biotechnology Industry | Healthcare Sector | Dr. Dwain K. Morris-Irvin M.P.H., MPH, Ph.D. CEO | OTC PINK Exchange | 67001N107 Cusip |
US Country | 3 Employees | - Last Dividend | 26 Aug 2020 Last Split | - IPO Date |